SCHEMBL14728665

SCHEMBL14728665

CC1(CO)CCN(c2c3c(c(C(N)=O)c4nc5ccccc5n24)C2CCC3C2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.55
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 5/20 0.36
GAA P10253 2/20 0.36
CASP1 P29466 3/20 0.34
TSHR P16473 2/20 0.34
CASP7 P55210 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KCNH2 Q12809 1/20 0.33
OGFRL1 Q5TC84 5/20 0.33
OPRK1 P41145 4/20 0.33
OPRM1 P35372 3/20 0.33
OPRD1 P41143 2/20 0.33
OPRL1 P41146 2/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14716329 0.89 PDE4B (0.68) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728617 0.84 PDE4B (0.51) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728662 0.83 PDE4B (0.43) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728575 0.83 KDM4E (0.46) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728664 0.81 PDE4B (0.41) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728635 0.81 PDE4B (0.64) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728273 0.81 PDE4B (0.80) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14716461 0.81 PDE4B (0.64) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728722 0.81 PDE4B (0.57) PDE4BKDM4EALDH1A1GAACASP1
SCHEMBL14728668 0.80 PDE4B (0.63) PDE4BKDM4EALDH1A1GAACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822688-B2 Imidazo[1,2-a]pyridine derivative ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-8822688-B2 Imidazo[1,2-a]pyridine derivative ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE PDE4B, PDE4A, PDE4C PDE4B 1/4885KDM4E 586/4885ALDH1A1 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.